Predictive mathematical models of cancer signalling pathways

Journal of Internal Medicine

Volumn 271, Issue 2, 2012, Pages 155-165

  Bachmann, J ^a   Raue, A ^b   Schilling, M ^a   Becker, V ^a,c   Timmer, J ^b   Klingmuller U ^a  

^a GERMAN CANCER RESEARCH CENTER   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cancer; Cell biology; Cytokines; Hematology; Lung cancer

Indexed keywords

ERYTHROPOIETIN RECEPTOR;

ANEMIA; CANCER CELL; CANCER THERAPY; CONFERENCE PAPER; FEEDBACK SYSTEM; HUMAN; INTRACELLULAR SIGNALING; LUNG CANCER; MATHEMATICAL MODEL; MAXIMUM LIKELIHOOD METHOD; ORDINARY DIFFERENTIAL EQUATION; PREDICTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; WORKFLOW;

ANEMIA; ANTINEOPLASTIC AGENTS; CELL SURVIVAL; CYTOKINES; ERYTHROPOIETIN; FORECASTING; HUMANS; LIKELIHOOD FUNCTIONS; LUNG NEOPLASMS; MATHEMATICS; MODELS, BIOLOGICAL; RECEPTORS, ERYTHROPOIETIN; RECOMBINANT PROTEINS; RISK FACTORS; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TRANSCRIPTION FACTORS;

EID: 84855968999     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2011.02492.x     Document Type: Conference Paper

References (50)

1. Batchelor E, Loewer A, Mock C, Lahav G. Stimulus-dependent dynamics of p53 in single cells. Mol Syst Biol 2011; 7: 488.
2. Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995; 80: 179-85.
3. Kholodenko BN, Hancock JF, Kolch W. Signalling ballet in space and time. Nat Rev Mol Cell Biol 2010; 11: 414-26.
4. Niethammer P, Bastiaens P, Karsenti E. Stathmin-tubulin interaction gradients in motile and mitotic cells. Science 2004; 303: 1862-6.
5. Spencer SL, Gaudet S, Albeck JG, Burke JM, Sorger PK. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 2009; 459: 428-32.
6. Chang HH, Hemberg M, Barahona M, Ingber DE, Huang S. Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Nature 2008; 453: 544-7.
7. Waks Z, Klein AM, Silver PA. Cell-to-cell variability of alternative RNA splicing. Mol Syst Biol 2011; 7: 506.
8. Aldridge BB, Burke JM, Lauffenburger DA, Sorger PK. Physicochemical modelling of cell signalling pathways. Nat Cell Biol 2006; 8: 1195-203.
9. Chen WW, Niepel M, Sorger PK. Classic and contemporary approaches to modeling biochemical reactions. Genes Dev 2010; 24: 1861-75.
10. Ashyraliyev M, Fomekong-Nanfack Y, Kaandorp JA, Blom JG. Systems biology: parameter estimation for biochemical models. FEBS J 2009; 276: 886-902.
11. Ay A, Arnosti DN. Mathematical modeling of gene expression: a guide for the perplexed biologist. Crit Rev Biochem Mol Biol 2011; 46: 137-51.
12. Morris MK, Saez-Rodriguez J, Sorger PK, Lauffenburger DA. Logic-based models for the analysis of cell signaling networks. Biochemistry 2010; 49: 3216-24.
13. Saez-Rodriguez J, Alexopoulos L, Zhang M, Morris MK, Lauffenburger DA, Sorger PK. Comparing signaling networks between normal and transformed hepatocytes using discrete logical models. Cancer Res 2011; 71: 5400-11.
14. Swameye I, Müller TG, Timmer J, Sandra O, Klingmüller U. Identification of nucleocytoplasmic cycling as a remote sensor in cellular signaling by databased modeling. Proc Natl Acad Sci U S A 2003; 100: 1028-33.
15. Taniguchi Y, Choi PJ, Li GW et al. Quantifying E. coli proteome and transcriptome with single-molecule sensitivity in single cells. Science 2010; 329: 533-8.
16. Kanehisa M, Araki M, Goto S et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res 2008; 36: D480-4.
17. Schilling M, Maiwald T, Bohl S et al. Quantitative data generation for systems biology: the impact of randomisation, calibrators and normalisers. Syst Biol (Stevenage) 2005; 152: 193-200.
18. Aksamitiene E, Hoek JB, Kholodenko B, Kiyatkin A. Multistrip Western blotting to increase quantitative data output. Electrophoresis 2007; 28: 3163-73.
19. Korf U, Derdak S, Tresch A et al. Quantitative protein microarrays for time-resolved measurements of protein phosphorylation. Proteomics 2008; 8: 4603-12.
20. Sevecka M, Wolf-Yadlin A, MacBeath G. Lysate microarrays enable high-throughput, quantitative investigations of cellular signaling. Mol Cell Proteomics 2011; 10: M110.005363.
21. Ciaccio MF, Wagner JP, Chuu CP, Lauffenburger DA, Jones RB. Systems analysis of EGF receptor signaling dynamics with microwestern arrays. Nat Methods 2010; 7: 148-55.
22. Hahn B, Böhm M, Raia V et al. One-source peptide/phosphopeptide standards for accurate phosphorylation degree determination. Proteomics 2011; 11: 490-4.
23. Cox J, Mann M. Quantitative, high-resolution proteomics for data-driven systems biology. Annu Rev Biochem 2011; 80: 273-99.
24. Eyrich B, Sickmann A, Zahedi RP. Catch me if you can: mass spectrometry-based phosphoproteomics and quantification strategies. Proteomics 2011; 11: 554-70.
25. Bodenmiller B, Aebersold R. Quantitative analysis of protein phosphorylation on a system-wide scale by mass spectrometry-based proteomics. Methods Enzymol 2010; 470: 317-34.
26. Schilling M, Pfeifer AC, Boh S, Klingmüller U. Standardizing experimental protocols. Curr Opin Biotechnol 2008; 19: 354-9.
27. Klingmüller U, Bauer A, Bohl S et al. Primary mouse hepatocytes for systems biology approaches: a standardized in vitro system for modelling of signal transduction pathways. Syst Biol (Stevenage) 2006; 153: 433-47.
28. Saez-Rodriguez J, Alexopoulos LG, Stolovitzky G. Setting the standards for signal transduction research. Sci Signal 2011; 4: pe10.
29. Samanta T, Ghosh JK. Model selection - An overview. Curr Sci 2001; 80: 1135-44.
30. Kreutz C, Timmer J. Systems biology: experimental design. FEBS J 2009; 276: 923-42.
31. Raue A, Kreutz C, Maiwald T et al. Structural and practical identifiability analysis of partially observed dynamical models by exploiting the profile likelihood. Bioinformatics 2009; 25: 1923-9.
32. Fisher R. On the mathematical foundations of theoretical statistics. Philos Trans R Soc Lond A 1922; 222: 309-68.
33. Conn AR, Gould NIM, Toint PL. Trust-Region Methods. Philadelphia, PA, USA: Society for Industrial and Applied Mathematics, 2000.
34. Kreutz C, Bartolome Rodriguez MM, Maiwald T et al. An error model for protein quantification. Bioinformatics 2007; 23: 2747-53.
35. Lehmann E, Leo E. Theory of Point Estimation. Weinheim, Germany: Wiley, 1983.
36. Walter E. Identifiability of Parametric Models. Elmsford, NY, USA: Pergamon Press, 1987.
37. Raue A, Kreutz C, Maiwald T, Klingmüller U, Timmer J. Addressing parameter identifiability by model-based experimentation. IET Syst Biol 2011; 5: 120-30.
38. Meeker W, Escobar L. Teaching about approximate confidence regions based on maximum likelihood estimation. Am Stat 1995; 49: 48-53.
39. Raue A, Becker V, Klingmüller U, Timmer J. Identifiability and observability analysis for experimental design in nonlinear dynamical models. Chaos 2010; 20: 045105.
40. Jelkmann W. Molecular biology of erythropoietin. Intern Med 2004; 43: 649-59.
41. Becker V, Schilling M, Bachmann J et al. Covering a broad dynamic range: information processing at the erythropoietin receptor. Science 2010; 328: 1404-8.
42. Socolovsky M, Nam H, Fleming MD, Haase VH, Brugnara C, Lodish HF. Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. Blood 2001; 98: 3261-73.
43. Cui Y, Riedlinger G, Miyoshi K et al. Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. Mol Cell Biol 2004; 24: 8037-47.
44. Grebien F, Kerenyi MA, Kovacic B et al. Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2. Blood 2008; 111: 4511-22.
45. Bachmann J, Raue A, Schilling M et al. Division of labor by dual feedback regulators controls JAK2/STAT5 signaling over broad ligand range. Mol Syst Biol 2011; 7: 516.
46. Gaudet S, Janes KA, Albeck JG, Pace EA, Lauffenburger DA, Sorger PK. A compendium of signals and responses triggered by prodeath and prosurvival cytokines. Mol Cell Proteomics 2005; 4: 1569-90.
47. Hardee ME, Arcasoy MO, Blackwell KL, Kirkpatrick JP, Dewhirst MW. Erythropoietin biology in cancer. Clin Cancer Res 2006; 12: 332-9.
48. Arcasoy MO, Jiang X, Haroon ZA. Expression of erythropoietin receptor splice variants in human cancer. Biochem Biophys Res Commun 2003; 307: 999-1007.
49. Okazaki T, Ebihara S, Asada M, Yamanda S, Niu K, Arai H. Erythropoietin promotes the growth of tumors lacking its receptor and decreases survival of tumor-bearing mice by enhancing angiogenesis. Neoplasia 2008; 10: 932-9.
50. Liang K, Esteva FJ, Albarracin C et al. Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation. Cancer Cell 2010; 18: 423-35.